Search Tag: immunotherapy

Executive Health Management

International-primary-immunodeficiencies-congress-ipic-2023

2023 08 Nov

<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b>Find IPIC on Social Media</b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/ipopi_info target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=85 height=85></a&gtRead more

IMAGING Management

Chili-conference-on-hybrid-imaging-live

2022 11 Nov

Find ESR on Social Media    Read more

Women's Health

Women-at-higher-risk-of-severe-adverse-events

2022 03 Jun

Past research has shown that women tend to have more side effects, or adverse events, from chemotherapy than men. Now a team from the SWOG Cancer Research Network that analyzed data on more than 20,000 patients from more than 200 clinical trials reports that women also have a higher risk of severe adverse events from two other major modes of cancer...Read more

Executive Health Management

Oncomyx-appoints-robert-williamson-chief-business-and-chief-financial-officer

2022 02 Mar

OncoMyx Therapeutics, a privately-held oncolytic virus immunotherapy company has announced the appointment of Robert Williamson as Chief Business and Chief Financial Officer. Mr. Williamson has more than two decades of experience in building, financing, and leading private and public biotechnology companies through critical phases of growth. At OncoMyx,...Read more

Executive Health Management

14th-international-congress-on-autoimmunity

2020 22 Jun

NOW ONLINE DUE TO COVID-19 Read more

Executive Health Management

Top-target-treatments-infographic

2019 22 May

Top target treatments and application of personalised medicine in healthcare Read more

Executive Health Management

Esmo-congress-2020

2020 19 Sep

CHANGED TO VIRTUAL CONGRESS Find ESMO on Social Media Read more

ICU Management

Immunotherapy-effects-on-sepsis

2019 01 May

A randomised controlled multicentre trial assessed for the first time the safety and pharmacokinetics of an antiprogrammed cell death-ligand 1 (anti–PD-L1) immune checkpoint inhibitor (BMS-936559; Bristol-Myers Squibb, Princeton, NJ) and its effect on immune biomarkers in participants with sepsis-associated immunosuppression. Results show that...Read more

ICU Management

Cytosorbents-expands-direct-sales-of-cytosorb-to-belgium-and-luxembourg

2016 04 Nov

CytoSorbents Corporation , a critical care immunotherapy leader commercializing its flagship  CytoSorb®  extracorporeal cytokine adsorber to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the addition of Belgium and Luxembourg to its direct sales territories.  CytoSorb is now distributed in 42...Read more

IMAGING Management

Chemoresistance-explained-new-clues-in-small-cell-lung-cancer

2016 04 Apr

Researchers in Austria have unraveled how small cell lung cancer (SCLC) is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy, they said. The research group headed by Gerhard...Read more

IMAGING Management

Noninvasive-imaging-of-immune-system-detects-tumours

2015 22 Apr

A new technique that allows real-time, noninvasive imaging of the immune system’s response to the presence of tumours offers a potential breakthrough both in diagnostics and in monitoring efficacy of cancer therapies. Developed in the lab of Whitehead Institute Member Hidde Ploegh, the method utilises the imaging power of positron emission tomography...Read more

IMAGING Management

Live-coverage-of-the-immune-system-at-work-via-pet-imaging

2015 20 Jan

Researchers at Tübingen University have developed a new technique to safely mark T-cells for non-invasive in vivo imaging to better understand what happens during immune reactions in the body. This technique enabled the investigators to track the T-cell movement in mice using positron emission technology (PET). Previous methods used to follow the movement...Read more

Lab Management

Injectable-3d-vaccines-could-fight-cancer-infectious-diseases

2014 15 Dec

According to a new study, a non-surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer as well as infectious diseases such as HIV. The study, conducted by researchers at the Wyss Institute for Biologically Inspired Engineering and Harvard's School of Engineering...Read more

IMAGING Management

Immunotherapy-could-stop-resistance-to-radiotherapy

2014 06 Oct

Using immunotherapy and radiotherapy simultaneously to treat cancers could prevent some patients from becoming resistant to treatment, according to researchers from The University of Manchester (England, UK). Combining the two therapies enabled the immune system to hunt down and destroy cancer cells that were not killed by the initial radiotherapy in...Read more

Pharmacy Management

Game-changer-for-melanoma-treatment

2014 10 Sep

The FDA has approved a drug for the treatment of advanced melanoma. Pembrolizumab, which goes by the brand name Keytruda, is expected to be a game-changing drug for treating patients with advanced melanoma and who are no longer responding to alternative treatments. It is developed by Merck & Co.  Keytruda is an immunotherapy drug that attacks PD-1,...Read more

ICU Management

Study-transplant-success-linked-to-immune-molecule-levels

2014 13 May

A study recently published in the Journal of Immunology Research reports that patients with highest levels of the most powerful version of the immune molecule HLA-G seem to have the lowest risk of rejecting their transplanted kidney. Dr. Anatolij Horuzsko, immunologist at the Medical College of Georgia at Georgia Regents University and the study's...Read more

Executive Health Management

Pancreatic-cancer-vaccine-being-trialed-in-uk

2014 11 Mar

Together with researchers from around the UK, a team of oncologists from The Clatterbridge Cancer Centre has been conducting a project to develop a ground-breaking cancer vaccine that can be utilised alongside traditional treatment methods in order to fight pancreatic cancer. Pancreatic cancer is the fifth biggest cause of cancer related deaths,...Read more